Lebanon, NJ, United States of America

John Rothman

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 195(Granted Patents)


Location History:

  • Lebanon, PA (US) (2017)
  • Lebanon, NJ (US) (1991 - 2024)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: John Rothman: Innovator in Autism and Anxiety Treatment

Introduction

John Rothman, based in Lebanon, NJ, is a prolific inventor with a remarkable portfolio of 22 patents. His contributions to the fields of autism and anxiety-related disorders have garnered significant attention, marking him as a key figure in therapeutic innovations.

Latest Patents

Among Rothman's latest patents are two groundbreaking inventions aimed at improving mental health treatment. The first patent focuses on "Compositions and methods for treating autism," which details innovative approaches to address core symptoms of autism through the administration of alpha-methyl-DL-tyrosine. This composition offers new hope for individuals affected by autism, potentially enhancing their quality of life. The second patent, "Compositions and methods for treating anxiety-related disorders," presents methods, compositions, and kits designed to treat various anxiety-related conditions, including Obsessive-Compulsive Disorder (OCD) and Social Anxiety Disorder (SAD). This invention aims to reduce anxiety and compulsive behaviors, providing valuable tools for those in need of effective therapies.

Career Highlights

Rothman's career includes significant stints at prestigious institutions such as the University of Pennsylvania and Advaxis, Inc. His work in these organizations has allowed him to collaborate with leading experts, contributing to advancements in therapeutic research and developing innovative solutions for mental health disorders.

Collaborations

Throughout his career, Rothman has had the privilege of working alongside renowned colleagues such as Yvonne Paterson and William J. Garner. These collaborations have enabled the fusion of expertise and creativity, driving forward the research and application of new treatment methodologies.

Conclusion

John Rothman's innovative patents and dedicated research efforts showcase his commitment to addressing vital mental health issues. His work has the potential to influence numerous lives and pave the way for future innovations in the treatment of autism and anxiety disorders. As he continues to explore and expand his research, the impact of his inventions will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…